Bara Badwan shares his 7 AI-themed takeaways from The Alliance for Artificial Intelligence in Healthcare (AAIH) conference. Read it here: https://lnkd.in/efNxrBRQ. #AI #healthcare
Intelligencia AI
Software Development
New York, New York 11,114 followers
Applying machine learning in drug development
About us
Intelligencia uses Artificial Intelligence to de-risk drug development. Our platform focuses on estimating the risk of clinical trials, and interpreting the multitude of factors that contribute to that risk. We therefore aim to bridge the gap between innovation and risk reduction, with the ultimate goal of bringing novel therapies to patients faster. Our interdisciplinary team of software engineers, AI practitioners, scientists, and drug developers brings together and interprets disparate data across the life sciences industry. Our platform offers a suite of functionalities that provide unprecedented data clarity and Machine-Learning fueled predictions to enable critical decision making. We currently work with several of the largest global pharmaceutical companies and mid-size and smaller biotechnology companies. Diseases will impact nearly every individual. At Intelligencia AI, we work to make a difference.
- Website
-
http://www.intelligencia.ai/
External link for Intelligencia AI
- Industry
- Software Development
- Company size
- 51-200 employees
- Headquarters
- New York, New York
- Type
- Privately Held
- Founded
- 2017
- Specialties
- Artificial Intelligence, Data Science, Machine Learning, Data Visualization, Experience Design, Healthcare, Pharmaceuticals, Biotechnology, Drug Development, and Clinical Trials
Locations
-
Primary
Get directions
180 Varick Street
6th Floor
New York, New York 10014, US
-
Get directions
Leoforos Syngrou 80-88
2nd Floor
Athens, Attiki 11741, GR
Employees at Intelligencia AI
-
Aristotelis Tsirigos
Professor at NYU School of Medicine.
-
Dimitrios Skaltsas
We are hiring! Co-Founder & CEO, Intelligencia AI: De-risking drug development| Inc. 5000| Executive in Residence, AI at INSEAD
-
Panos Karelis
Bringing best-in-class insights to biopharma | Director of Insights Excellence at Intelligencia.ai
-
Alexandra Ferraro
Strategic and Tactical Marketing Leader 💠 Data-Driven Strategist 💠 Market Expansion and Vertical Growth Leader 💠Experienced Full-Stack Marketing…
Updates
-
Last week, our company was spotlighted during the “business applications of AI” section of the OECD conference “Futures of #AI Governance: Co-Creating an Approach for Transforming Economies and Societies” as one of the AI companies with a presence in Greece. Watch the video to hear from our CEO and co-founder, Dimitrios Skaltsas, and learn how we're positively impacting #drugdevelopment.
-
As October marks #LiverCancer Awareness Month, we analyzed our data to gain a high-level view of the current and future state of #drugdevelopment. Read this and other insights on our blog https://lnkd.in/e3vMWyKz.
-
Next month, Gary Summers and Andrew Rainboldt will take the virtual stage to share their research and findings on how causal inference can increase the probability of success in clinical trials. Save your spot here: https://lnkd.in/dc-T2xj7 #pharmaceutical #drugdevelopment You'll learn: ➡️ How to use causal inference to understand the impact of clinical design decisions, specifically focusing on biomarkers inclusion criterion and clinical trial success ➡️ The importance of combining quality data with the proper methodologies for more informed decisions ➡️ How to apply state-of-the-art methodologies to clinical trials to uncover underlying causal relationships that can optimize decision-making ➡️ The correlation between biomarkers and the probability of technical and regulatory success
-
-
We compared data from the American Society of Clinical Oncology (ASCO) for 2023 vs. 2024 to uncover trends, highlight our time-stamped pre- and post-ASCO predictions and discuss the business impact. Read the complete analysis here ➡️ https://lnkd.in/ebiHNEc2 #oncology #drugdevelopment #pharmaceutical
-
We're back in Boston next week with Why Summits! Marianna Esposito will share real-world applications of our patented AI solution to help de-risk portfolio strategy and elevate decision-making for pharmaceutical professionals.
🎮 Ready to Level-Up Your Portfolio Strategy? It’s time to stop playing on easy mode and level-up with AI! 🕹️ Marianna Esposito, Director, Business Development at Intelligencia AI, is here to show you how AI can help de-risk your portfolio strategy and take your decision-making to the next level. Say goodbye to guesswork and hello to game-changing insights. Are you ready to play smarter, not harder? Register here: https://lnkd.in/dmKigmrk #AILevelUp #PortfolioMastery #RiskFreeStrategy #PharmaGameChanger #AIPoweredDecisions
-
-
This week, we're off to Boston to learn from our #pharma industry colleagues about the latest and greatest in decision-making in program and portfolio management. We're guessing that #AI will certainly be one of the many topics!
Connecting Biopharma Leaders to Advance Pharmaceutical R&D in Clinical Trial Operations, Alliance Management, Data Science & Informatics, Portfolio & Resource Management
One week to go!! But it is not too late to register to attend CHI’s 21st Annual Executive Decision Making for Pharm & Biotech: Program & Portfolio Management and Strategic Resource Management. Take advantage of this unique opportunity to hear from and meet a stellar lineup of speakers, including Kundini Amin Mathilde Bryse Stephen Cho Paul B Cook, PhD, PMP Jennifer Daubenspeck Melquiades de Jesus Thomas De Vis Michael Ferrante Stuart Fort Sean Gallagher Andrea James Elayne K. Ivan Kugener, MD Christopher Larson Sabine Lenders Leslie Lippard Mike Myers Charles Naaman Mary Lou Panzano Charles Persinger Peter Ray Alexander Rucci Michelle Shogren Joe Stalder Gary Summers Dan Tierno Greg Wayne, Ph.D., MBA Saeid (Sam) Yazdani, MBA, PMP, LSSBB Edoardo Madussi https://bit.ly/3Qk5qFU #ExecutiveDecisionMaking #PortfolioManagement #ProgramManagement
-
-
For this month's employee Q&A, we sat down with Marina Anastasiou, PhD, MBAc. We learned more about what inspired her to say 'yes' to working at Intelligencia AI, what she finds most rewarding about her work, and even her favorite meal. Read the full Q&A here: https://lnkd.in/eGkrw9P8 #pharma #AI
-
-
This week, Bara Badwan is representing us on the West Coast at The Alliance for Artificial Intelligence in Healthcare (AAIH) and sharing our work on how our patented #AI solution identifies promising early-stage #biopharma assets and companies. You can read more about that here: https://lnkd.in/eTJReqfj. #pharmaceutical #portfoliostrategy
TODAY IS THE DAY! The The Alliance for Artificial Intelligence in Healthcare (AAIH) 2024 Annual Member Meeting begins today, September 30th 2024! If you have registered and will be attending, we look forward to seeing you on Genentech Campus in San Francisco today (September 30th) and tomorrow (October 1st)! If you are not joining, be sure to follow along for news, updates, and insightful information and takeaways that will come from this two day summit! #AAIH #annualmembermeeting #aaihannualmembermeeting
-